MedTrace Logo

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

NCT01800877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-03-12

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.

Conditions

Interventions

DRUG

Vasopressors

Sponsors & Collaborators

  • Canadian Critical Care Trials Group

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Fonds de la Recherche en Santé du Québec

    collaborator OTHER_GOV

  • Francois Lamontagne

    lead OTHER

Principal Investigators

  • Francois Lamontagne, MD · Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800877 on ClinicalTrials.gov